DOI: 10.2337/db06-0330 © 2006 by the American Diabetes Association Altered Adipose and Plasma Sphingolipid Metabolism in ObesityA Potential Mechanism for Cardiovascular and Metabolic Risk
1 Division of Vascular Biology, La Jolla Institute for Molecular Medicine, San Diego, California Address correspondence and reprint requests to Dr. Fahumiya Samad, Division of Vascular Biology, La Jolla Institute for Molecular Medicine, San Diego, CA 92121. E-mail: fsamad{at}ljimm.org
Abbreviations:
ASMase, acid sphingomyelinase; GM3, N-acetylneuraminylgalactosylceramide; HPLC, high-performance liquid chromatography; IL, interleukin; KC, keratinocyte-derived chemokine; MCP-1, monocyte chemoattractant protein-1; NSMase, neutral sphingomyelinase; PAI-1, plasminogen activator inhibitor-1; S1P, sphingosine 1-phosphate; SPT, serine palmitoyl transferase; TMS, tandem mass spectrometry; TNF-
The adipose tissue has become a central focus in the pathogenesis of obesity-mediated cardiovascular and metabolic disease. Here we demonstrate that adipose sphingolipid metabolism is altered in genetically obese (ob/ob) mice. Expression of enzymes involved in ceramide generation (neutral sphingomyelinase [NSMase], acid sphingomyelinase [ASMase], and serine-palmitoyl-transferase [SPT]) and ceramide hydrolysis (ceramidase) are elevated in obese adipose tissues. Our data also suggest that hyperinsulinemia and elevated tumor necrosis factor (TNF)-
This article has been cited by other articles:
|
|
|
||||||||||||||||||||||||||||||||||||||